We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Eton Pharmaceuticals announced Biorphen®, the first and only FDA-approved ready-to-use formulation of phenylephrine for the treatment of clinically important hypotension ...
Lupin’s Phenylephrine and Ketorolac Intraocular Solution, 1 per cent 0.3 per cent is the generic version of Omidria Intraocular Solution, 1 per cent 0.3 per cent of Omeros Corporation
Lupin’s Phenylephrine and Ketorolac Intraocular Solution, 1 per cent 0.3 per cent is the generic version of Omidria Intraocular Solution, 1 per cent 0.3 per cent of Omeros Corporation